Cargando…
Renal Proximal Tubular Cells: A New Site for Targeted Delivery Therapy of Diabetic Kidney Disease
Diabetic kidney disease (DKD) is a major complication of diabetes mellitus (DM) and the leading cause of end-stage kidney disease (ESKD) worldwide. A significant number of drugs have been clinically investigated for the treatment of DKD. However, a large proportion of patients still develop end-stag...
Autores principales: | Li, Hao, Dai, Wenni, Liu, Zhiwen, He, Liyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786989/ https://www.ncbi.nlm.nih.gov/pubmed/36558944 http://dx.doi.org/10.3390/ph15121494 |
Ejemplares similares
-
Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease
por: Chen, Xian, et al.
Publicado: (2022) -
Targeting Renal Proximal Tubule Cells in Obesity-Related Glomerulopathy
por: Ye, Muyao, et al.
Publicado: (2023) -
Biopolymer-Based Nanosystems: Potential Novel Carriers for Kidney Drug Delivery
por: Li, Hao, et al.
Publicado: (2023) -
The Loss of Mitochondrial Quality Control in Diabetic Kidney Disease
por: Dai, Wenni, et al.
Publicado: (2021) -
RvD1 Attenuated Susceptibility to Ischemic AKI in Diabetes by Downregulating Nuclear Factor-κ B Signal and Inhibiting Apoptosis
por: Li, Zheng, et al.
Publicado: (2021)